We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$57.2B
AUM Growth
+$4B
Cap. Flow
-$1.18B
Cap. Flow %
-2.06%
Top 10 Hldgs %
12.48%
Holding
3,271
New
835
Increased
795
Reduced
814
Closed
718

Sector Composition

Rank Sector Weight
1 Technology 9.59%
2 Consumer Discretionary 8.82%
3 Industrials 8.12%
4 Financials 7.95%
5 Healthcare 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMH icon
626
American Homes 4 Rent
AMH
$12.2B
$18.3M 0.03%
496,606
-2,113,186
-81% -$75.4M
LTC
627
LTC Properties
LTC
$2.05B
$18.2M 0.03%
560,973
+519,340
+1,247% +$16.5M
XLY icon
628
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
$18M 0.03%
195,882
-150,764
-43% -$13.4M
XLP icon
629
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$17.9M 0.03%
234,200
-51,600
-18% -$3.82M
BA icon
630
CALL
Boeing
BA
$184B
$17.9M 0.03%
92,600
-73,600
-44% -$15.1M
DOCU
631
CALL
DocuSign
DOCU
$11.3B
$17.9M 0.03%
+300,000
New +$16.9M
PFE icon
632
Pfizer
PFE
$152B
$17.9M 0.03%
643,376
-1,726,673
-73% -$47.9M
ALAB icon
633
Astera Labs
ALAB
$54.1B
$17.8M 0.03%
+240,317
New +$17.8M
ONB icon
634
Old National Bancorp
ONB
$10.3B
$17.8M 0.03%
+1,023,505
New +$16.9M
MKSI icon
635
MKS Inc
MKSI
$19.9B
$17.8M 0.03%
133,865
-61,321
-31% -$7.13M
IOVA icon
636
Iovance Biotherapeutics
IOVA
$2.94B
$17.8M 0.03%
1,200,864
-2,725,295
-69% -$31.7M
WBS icon
637
Webster Financial
WBS
$12.8B
$17.8M 0.03%
349,747
+209,965
+150% +$10.3M
CMCSA icon
638
PUT
Comcast
CMCSA
$91.1B
$17.7M 0.03%
409,400
+121,500
+42% +$5.24M
TGT icon
639
PUT
Target
TGT
$69.2B
$17.7M 0.03%
100,000
CROX icon
640
CALL
Crocs
CROX
$6.32B
$17.7M 0.03%
122,800
+94,800
+339% +$10.8M
NARI
641
DELISTED
Inari Medical, Inc. Common Stock
NARI
$17.7M 0.03%
367,988
+184,051
+100% +$9.83M
CYTK icon
642
CALL
Cytokinetics
CYTK
$10.6B
$17.6M 0.03%
251,100
-89,000
-26% -$6.88M
PGRE
643
DELISTED
Paramount Group
PGRE
$17.6M 0.03%
3,751,265
-1,065,140
-22% -$5.02M
BNTX icon
644
BioNTech
BNTX
$23.3B
$17.5M 0.03%
+190,102
New +$18.2M
CAR icon
645
Avis
CAR
$4.96B
$17.5M 0.03%
+142,902
New +$19.7M
MEOH icon
646
Methanex
MEOH
$4.2B
$17.5M 0.03%
391,706
-100,733
-20% -$4.49M
GEO icon
647
The GEO Group
GEO
$4.18B
$17.5M 0.03%
+1,236,223
New +$14.7M
MO icon
648
CALL
Altria Group
MO
$109B
$17.4M 0.03%
+400,000
New +$16.6M
JEF icon
649
Jefferies Financial Group
JEF
$12.7B
$17.4M 0.03%
395,488
+364,242
+1,166% +$15.2M
HSY icon
650
Hershey
HSY
$36.6B
$17.4M 0.03%
89,463
+85,050
+1,927% +$16.4M

Similar funds

Balyasny Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Balyasny Asset Management held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Balyasny Asset Management's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Balyasny Asset Management's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
  • Balyasny Asset Management added most to Broadcom in Q1 2024, an estimated $342M increase.
  • Balyasny Asset Management's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
  • Balyasny Asset Management fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
  • Balyasny Asset Management's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
  • Balyasny Asset Management opened 835 new positions and closed 718 in Q1 2024.
  • Balyasny Asset Management's portfolio value rose 7.5% quarter-over-quarter to $57.2B.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.